Inhibition of BCR/ABL protein expression by miR-203 sensitizes for imatinib mesylate.
Selective inhibition of BCR/ABL expression by RNA interference has been demonstrated as an effective strategy in CML treatment and a reversal to imatinib resistance. microRNAs (miRNAs) are small regulatory RNAs involved in post-transcriptional gene regulation. miR-203 is supposed to directly regulat...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science (PLoS)
2013-01-01
|
| Sarja: | PLoS ONE |
| Linkit: | https://doi.org/10.1371/journal.pone.0061858 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|